Navigation Links
Food Allergens Show Up in Unexpected Places
Date:7/6/2008

Street vendors, fairs replacing trans fats with peanut oil -- all can spell trouble

SUNDAY, July 6 (HealthDay News) -- While it may be hard to resist the sight and smell of food at summer festivals and fairs, people with food allergies need to be extra vigilant with such food, advises the American Academy of Allergy, Asthma & Immunology (AAAAI).

"There are many questions about ingredients, preparations and possible cross-contamination that if left unanswered could lead to an allergic reaction," Dr. Amal H. Assa'ad, chairman of the academy's Adverse Reactions to Food Committee, said in a prepared statement.

Each year in the United States, up to 150 people die from anaphylaxis caused by food allergies, according to the AAAAI. Most people who experience allergic reactions to food experience skin irritation, asthma symptoms or gastrointestinal upset.

The 12 million Americans with food allergies should remember that food allergens can be present in unexpected places. For example, in an effort to eliminate trans fats, many vendors have started using peanut oil or soybean oil in their fryers.

The AAAI offers the following tips for avoiding serious allergic reactions to food:

  • Get checked to see if you have food allergies.
  • Avoid foods to which you're allergic.
  • When eating away from home, always ask about the ingredients in food items and inform party hosts, service staff or vendors of the severity of your allergy.
  • Carefully read all food labels.
  • If you've had a severe reaction in the past, you should always carry self-injectable epinephrine.

More information

The American Academy of Family Physicians has more about food allergies.



-- Robert Preidt
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Leiner Health Products Issues Allergy Alert on Undeclared Allergens in Liquimax(R) Multivitamin
2. Immune system pathway identified to fight allergens, asthma
3. Leave Bedroom Allergens High and Dry This Spring!
4. Hissing cockroaches are popular, but they also host potent mold allergens
5. Unexpected role: EGFR protects cancer cells from starving
6. Osteotech Announces the Unexpected Passing of Audit Committee Member Leads to Receipt of Nasdaq Deficiency Letter
7. An unexpected way to cause leukemia
8. Longer flu season and unexpected strains make prevention plan key
9. LA BioMed researcher says unexpected increase in cancer risk found
10. Leicester scientist announces unexpected and exciting advance in study of cancer type
11. Men Are Vein Too: Innovative Treatment Sparks Unexpected Consumer Trend
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Launches Orphan Drug Workshop at KGI 2Daniel K. Spiegelman Elected to Board of Directors of Omeros 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 1Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 2Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 3Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 4Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 5Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 1Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 2Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 3Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 4Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 5Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 6Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 7Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 8Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 9Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 10Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 11Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 12Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 13Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 14Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 15Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 16Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 17Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 18Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 19Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 20Geneticists hunt for scleroderma triggers 60340 1Geneticists hunt for scleroderma triggers 60340 2